Business News | Booster Vaccine for Omicron Variant Gets Emergency Use Approval
Get latest articles and stories on Business at LatestLY. The mRNA-based booster vaccine GEMCOVAC®-OM, developed to provide immunity against the Omicron variant of Covid-19, has received approval from the regulator Drug Control General of India (DCGI) for emergency use.
New Delhi [India], June 20 (ANI): The booster vaccine GEMCOVAC®-OM, developed to provide immunity against the Omicron variant of Covid-19, has received approval from the regulator Drug Control General of India (DCGI) for emergency use.
The mRNA-based vaccine was developed using the indigenous platform technology by Gennova Biopharmaceuticals Ltd. and supported under the Mission COVID Suraksha, implemented by Biotechnology Industry Research Assistance Council (BIRAC), said a Ministry of Science and Technology release.
Also Read | Special Olympics World Games 2023: T Vishal Bags Silver Medal.
It is a thermostable vaccine, which does not require ultra-cold chain infrastructure used for other approved mRNA-based vaccines, making it easy for deployment across the country.
"It is delivered intra-dermally using a needle-free injection device system. When administered intradermally in participants as a booster, it generated significantly higher immune responses. The clinical outcome demonstrates the need for variant-specific vaccines for desired immune response," the release said. (ANI)
Also Read | Samsung Galaxy F54 5G Goes on Sale in India Starting June 20; Details.
(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)